Abstract
Cancer resection specimens are usually reported using standardised proformas that consist of a list of elements, which include core (required) and non-core (recommended) items. Although all elements are generally included in the reports, the clinical importance of a particular parameter often depends on a variety of factors, including the clinical setting, local management guidelines and other pathological parameters. In this review, we briefly outline how histopathology data are used to guide management of patients with endometrial and tubo-ovarian cancers, the most common gynaecological malignancies, and provide advice as to which data elements are important in particular scenarios.
Subject
General Medicine,Pathology and Forensic Medicine
Reference33 articles.
1. The International Society of gynecological pathologists (ISGyP) endometrial carcinoma project;McCluggage;Int J Gynecol Pathol,2019
2. Matias-Guiu X , Anderson L , Buza N . International Collaboration on Cancer Reporting: Endometrial cancer histopathology reporting guide. 4th edn, 2021. http://www.iccr-cancer.org/datasets/published-datasets/female-reproductive/endometrial
3. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
4. Gilks CB , Davidson B , Köbel M . International Collaboration on Cancer Reporting: Ovary, fallopian tube and primary peritoneal carcinoma histopathology reporting guide. 2nd edn, 2021. http://www.iccr-cancer.org/datasets/published-datasets/female-reproductive/ovary-ft-pp
5. ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease